Research progress on clinical outcomes of hybrid coronary revascularization_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

LI Dongjie , GAO Jie ,  SU Pixiong

Department of Cardiac Surgery, Heart Center, Chaoyang Hospital, Capital Medical University, Beijing, 100020, P.R.China;

Corresponding?author：

SU Pixiong, Email: supixiong1130@163.com

Keywords：

Hybrid coronary revascularization; coronary artery bypass grafting; percutaneous coronary intervention; minimally invasive direct coronary artery bypass grafting; review

DOI：

10.7507/1007-4848.202101018

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Hybrid coronary revascularization (HCR) combines the advantages of minimally invasive direct coronary artery bypass grafting (MIDCAB) and percutaneous coronary intervention (PCI), and avoids its relative shortcomings, which has received particular attention in recent years. HCR seems to have become the third revascularization strategy for multi-vessel disease in coronary heart diseases. However, the clinical researches on HCR are still limited. This article will systematically review the comparison of HCR with coronary artery bypass grafting (CABG) and PCI, the results of HCR in specific patients, and the clinical results of different HCR strategies.

Citation： LI Dongjie, GAO Jie, SU Pixiong. Research progress on clinical outcomes of hybrid coronary revascularization. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2021, 28(6): 645-649. doi: 10.7507/1007-4848.202101018 Copy

1.	Bangalore S, Guo Y, Samadashvili Z, et al. Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N Engl J Med, 2015, 372(13): 1213-1222.
2.	Cavalcante R, Sotomi Y, Zeng Y, et al. Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery. Heart, 2017, 103(6): 428-433.
3.	Tatoulis J, Buxton BF, Fuller JA. Patencies of 2127 arterial to coronary conduits over 15 years. Ann Thorac Surg, 2004, 77(1): 93-101.
4.	Goldman S, Zadina K, Moritz T, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: Results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol, 2004, 44(11): 2149-2156.
5.	Angelini GD, Wilde P, Salerno TA, et al. Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularisation. Lancet, 1996, 347(9003): 757-758.
6.	Lowenstern A, Wu J, Bradley SM, et al. Current landscape of hybrid revascularization: A report from the NCDR CathPCI Registry. Am Heart J, 2019, 215: 167-177.
7.	Harskamp RE, Brennan JM, Xian Y, et al. Practice patterns and clinical outcomes after hybrid coronary revascularization in the United States: An analysis from the Society of Thoracic Surgeons Adult Cardiac Database. Circulation, 2014, 130(11): 872-879.
8.	G?sior M, Zembala MO, Tajstra M, et al. Hybrid revascularization for multivessel coronary artery disease. JACC Cardiovasc Interv, 2014, 7(11): 1277-1283.
9.	Tajstra M, Hrapkowicz T, Hawranek M, et al. Hybrid coronary revascularization in selected patients with multivessel disease: 5-year clinical outcomes of the prospective randomized pilot study. JACC Cardiovasc Interv, 2018, 11(9): 847-852.
10.	Esteves V, Oliveira MAP, Feitosa FS, et al. Late clinical outcomes of myocardial hybrid revascularization versus coronary artery bypass grafting for complex triple-vessel disease: Long-term follow-up of the randomized MERGING clinical trial. Catheter Cardiovasc Interv, 2021, 97(2): 259-264.
11.	Ganyukov V, Kochergin N, Shilov A, et al. Randomized clinical trial of surgical vs. percutaneous vs. hybrid revascularization in multivessel coronary artery disease: Residual myocardial ischemia and clinical outcomes at one year-hybrid coronary revascularization versus dtenting or durgery (HREVS). J Interv Cardiol, 2020, 2020: 5458064.
12.	Reynolds AC, King N. Hybrid coronary revascularization versus conventional coronary artery bypass grafting: Systematic review and meta-analysis. Medicine (Baltimore), 2018, 97(33): e11941.
13.	Sardar P, Kundu A, Bischoff M, et al. Hybrid coronary revascularization versus coronary artery bypass grafting in patients with multivessel coronary artery disease: A meta-analysis. Catheter Cardiovasc Interv, 2018, 91(2): 203-212.
14.	Hannan EL, Wu Y, Cozzens K, et al. Hybrid coronary revascularization versus conventional coronary artery bypass surgery: Utilization and comparative outcomes. Circ Cardiovasc Interv, 2020, 13(10): e009386.
15.	Puskas JD, Halkos ME, DeRose JJ, et al. Hybrid coronary revascularization for the treatment of multivessel coronary artery disease: A multicenter observational study. J Am Coll Cardiol, 2016, 68(4): 356-365.
16.	Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med, 2012, 367(25): 2375-2384.
17.	Harskamp RE, Walker PF, Alexander JH, et al. Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus. Am Heart J, 2014, 168(4): 471-478.
18.	M?kikallio T, Holm NR, Lindsay M, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): A prospective, randomised, open-label, non-inferiority trial. Lancet, 2016, 388(10061): 2743-2752.
19.	Kawai Y, Niitsu H, Yanagisawa T, et al. Hybrid coronary revascularization of minimally invasive coronary artery bypass grafting and percutaneous coronary intervention in a patient with left main coronary stenosis. Kyobu Geka, 2017, 70(6): 414-417.
20.	Harskamp RE, Puskas JD, Tijssen JG, et al. Comparison of hybrid coronary revascularization versus coronary artery bypass grafting in patients≥65 years with multivessel coronary artery disease. Am J Cardiol, 2014, 114(2): 224-229.
21.	Patel NC, Hemli JM, Kim MC, et al. Short- and intermediate-term outcomes of hybrid coronary revascularization for double-vessel disease. J Thorac Cardiovasc Surg, 2018, 156(5): 1799-1807.
22.	Qiu J, Zhu P, Liu Z, et al. Hybrid coronary revascularization versus off-pump coronary artery bypass grafting and percutaneous coronary intervention for the treatment of two-vessel coronary artery disease with proximal left anterior descending artery stenosis. J Thorac Dis, 2019, 11(6): 2402-2409.
23.	Zhao DX, Leacche M, Balaguer JM, et al. Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room. J Am Coll Cardiol, 2009, 53(3): 232-241.
24.	Shen L, Hu S, Wang H, et al. One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution. J Am Coll Cardiol, 2013, 61(25): 2525-2533.
25.	沈劉忠, 胡盛壽, 呂鋒, 等. 一站式復合技術與冠狀動脈旁路移植術及經皮冠狀動脈介入治療在冠狀動脈多支病變治療中的對比研究. 中國循環雜志, 2018, 33(1): 24-29.
26.	Choi HJ, Kang J, Song H, et al. Comparison of coronary artery bypass graft-first and percutaneous coronary intervention-first approaches for 2-stage hybrid coronary revascularization. Korean J Thorac Cardiovasc Surg, 2017, 50(4): 247-254.
27.	Kitahara H, Hirai T, McCrorey M, et al. Hybrid coronary revascularization: Midterm outcomes of robotic multivessel bypass and percutaneous interventions. J Thorac Cardiovasc Surg, 2019, 157(5): 1829-1836.

1. Bangalore S, Guo Y, Samadashvili Z, et al. Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N Engl J Med, 2015, 372(13): 1213-1222.
2. Cavalcante R, Sotomi Y, Zeng Y, et al. Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery. Heart, 2017, 103(6): 428-433.
3. Tatoulis J, Buxton BF, Fuller JA. Patencies of 2127 arterial to coronary conduits over 15 years. Ann Thorac Surg, 2004, 77(1): 93-101.
4. Goldman S, Zadina K, Moritz T, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: Results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol, 2004, 44(11): 2149-2156.
5. Angelini GD, Wilde P, Salerno TA, et al. Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularisation. Lancet, 1996, 347(9003): 757-758.
6. Lowenstern A, Wu J, Bradley SM, et al. Current landscape of hybrid revascularization: A report from the NCDR CathPCI Registry. Am Heart J, 2019, 215: 167-177.
7. Harskamp RE, Brennan JM, Xian Y, et al. Practice patterns and clinical outcomes after hybrid coronary revascularization in the United States: An analysis from the Society of Thoracic Surgeons Adult Cardiac Database. Circulation, 2014, 130(11): 872-879.
8. G?sior M, Zembala MO, Tajstra M, et al. Hybrid revascularization for multivessel coronary artery disease. JACC Cardiovasc Interv, 2014, 7(11): 1277-1283.
9. Tajstra M, Hrapkowicz T, Hawranek M, et al. Hybrid coronary revascularization in selected patients with multivessel disease: 5-year clinical outcomes of the prospective randomized pilot study. JACC Cardiovasc Interv, 2018, 11(9): 847-852.
10. Esteves V, Oliveira MAP, Feitosa FS, et al. Late clinical outcomes of myocardial hybrid revascularization versus coronary artery bypass grafting for complex triple-vessel disease: Long-term follow-up of the randomized MERGING clinical trial. Catheter Cardiovasc Interv, 2021, 97(2): 259-264.
11. Ganyukov V, Kochergin N, Shilov A, et al. Randomized clinical trial of surgical vs. percutaneous vs. hybrid revascularization in multivessel coronary artery disease: Residual myocardial ischemia and clinical outcomes at one year-hybrid coronary revascularization versus dtenting or durgery (HREVS). J Interv Cardiol, 2020, 2020: 5458064.
12. Reynolds AC, King N. Hybrid coronary revascularization versus conventional coronary artery bypass grafting: Systematic review and meta-analysis. Medicine (Baltimore), 2018, 97(33): e11941.
13. Sardar P, Kundu A, Bischoff M, et al. Hybrid coronary revascularization versus coronary artery bypass grafting in patients with multivessel coronary artery disease: A meta-analysis. Catheter Cardiovasc Interv, 2018, 91(2): 203-212.
14. Hannan EL, Wu Y, Cozzens K, et al. Hybrid coronary revascularization versus conventional coronary artery bypass surgery: Utilization and comparative outcomes. Circ Cardiovasc Interv, 2020, 13(10): e009386.
15. Puskas JD, Halkos ME, DeRose JJ, et al. Hybrid coronary revascularization for the treatment of multivessel coronary artery disease: A multicenter observational study. J Am Coll Cardiol, 2016, 68(4): 356-365.
16. Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med, 2012, 367(25): 2375-2384.
17. Harskamp RE, Walker PF, Alexander JH, et al. Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus. Am Heart J, 2014, 168(4): 471-478.
18. M?kikallio T, Holm NR, Lindsay M, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): A prospective, randomised, open-label, non-inferiority trial. Lancet, 2016, 388(10061): 2743-2752.
19. Kawai Y, Niitsu H, Yanagisawa T, et al. Hybrid coronary revascularization of minimally invasive coronary artery bypass grafting and percutaneous coronary intervention in a patient with left main coronary stenosis. Kyobu Geka, 2017, 70(6): 414-417.
20. Harskamp RE, Puskas JD, Tijssen JG, et al. Comparison of hybrid coronary revascularization versus coronary artery bypass grafting in patients≥65 years with multivessel coronary artery disease. Am J Cardiol, 2014, 114(2): 224-229.
21. Patel NC, Hemli JM, Kim MC, et al. Short- and intermediate-term outcomes of hybrid coronary revascularization for double-vessel disease. J Thorac Cardiovasc Surg, 2018, 156(5): 1799-1807.
22. Qiu J, Zhu P, Liu Z, et al. Hybrid coronary revascularization versus off-pump coronary artery bypass grafting and percutaneous coronary intervention for the treatment of two-vessel coronary artery disease with proximal left anterior descending artery stenosis. J Thorac Dis, 2019, 11(6): 2402-2409.
23. Zhao DX, Leacche M, Balaguer JM, et al. Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room. J Am Coll Cardiol, 2009, 53(3): 232-241.
24. Shen L, Hu S, Wang H, et al. One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution. J Am Coll Cardiol, 2013, 61(25): 2525-2533.
25. 沈劉忠, 胡盛壽, 呂鋒, 等. 一站式復合技術與冠狀動脈旁路移植術及經皮冠狀動脈介入治療在冠狀動脈多支病變治療中的對比研究. 中國循環雜志, 2018, 33(1): 24-29.
26. Choi HJ, Kang J, Song H, et al. Comparison of coronary artery bypass graft-first and percutaneous coronary intervention-first approaches for 2-stage hybrid coronary revascularization. Korean J Thorac Cardiovasc Surg, 2017, 50(4): 247-254.
27. Kitahara H, Hirai T, McCrorey M, et al. Hybrid coronary revascularization: Midterm outcomes of robotic multivessel bypass and percutaneous interventions. J Thorac Cardiovasc Surg, 2019, 157(5): 1829-1836.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Research progress on clinical outcomes of hybrid coronary revascularization

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content